Liver Transplantation for Unresectable GIST Liver Metastases
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Liver Transplantation
Felipe Alconchel
Murcia, Spain
Overall Survival
Survival
Time frame: Through study completion, an average of 2 years
Graft Survival
Liver graft Survival
Time frame: Through study completion, an average of 2 years
Relapse free survival
Time frame: Through study completion, an average of 2 years
Disease free survival
Time frame: Through study completion, an average of 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.